Last updated: 2026-09-06 18:48:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Repare Therapeutics Inc. (RPTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Repare Therapeutics Inc. (RPTX) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, RPTX traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, Repare Therapeutics Inc. (RPTX) moved from $2.57 to $2.65, representing a gain of 3.11% ($0.08).
The stock traded between $2.50 and $2.65 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.23 million shares, up versus the previous seven-day period, indicating higher trading activity.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 129 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Repare Therapeutics Inc. (RPTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.